An important breakthrough in understanding the Zika virus structure and its behaviour has been highlighted in a study by Duke-NUS Medical School (Duke-NUS) scientists.
Published online on 19 April 2016 in the journal Nature, their findings reveal the Zika virus structure and identify potential sites on the virus to target with therapeutics. This knowledge will help worldwide efforts to fight the poorly understood virus, which is a currently a public health and research priority.
Associate Professor Shee-Mei Lok and her team from Duke-NUS imaged the Zika virus under a cryo-electron microscope from a large number of purified viral particles. By using thousands of images, they reconstructed a high-resolution cryo-electron microscopy structure of the Zika virus.
The high-resolution structure of the Zika virus showed that the overall virus architecture is similar to other flaviviruses such as the West Nile and dengue viruses. However, the team found that the Zika virus is more thermally stable than the dengue virus, and is also structurally stable even when incubated at 40 degrees Celsius, mimicking the body temperature of extremely feverish patients after virus infection.
The structure also revealed that the Zika virus surface proteins have tighter interactions compared to the dengue virus, therefore making it more stable than the dengue virus. This may explain its ability to survive in harsh conditions such as semen, saliva and urine. In addition to transmission by the bite of an infected mosquito, the structural stability of the virus makes it more resilient, which likely explains its special ability to transmit through sexual contact. Similar viruses, such as dengue and West Nile, do not spread through sexual contact.
Overall, the findings suggest that antibodies or drugs that destabilise the structure of the Zika virus may help to reduce the severity of the disease or limit the spread of the virus.
"This is exciting, as our structure will provide important clues to other researchers around the world who are working to find therapeutic agents against the Zika virus," said Assoc Prof Lok from the Emerging Infectious Diseases Programme at Duke-NUS.
"Additionally, we have shown that the Zika virus contains structures that are unique from the viruses in the same family that affect brains, such as the West Nile virus, and also those that cause fever, such as the dengue virus. These structures can be mutated to better understand how they influence the Zika virus infection in humans and can also potentially lead to the development of a safe vaccine that has reduced side effects."
Assoc Prof Lok's next step is to understand the effect of potent antibodies on the Zika virus. By examining the structure presented in this study, her team will work to determine how the antibodies could be used to kill the virus. They also hope to identify which potent antibodies could be used to treat people in emergency situations, such as a sudden outbreak or in the case of infection during pregnancy.
Research suggests no need for yellow fever vaccine booster after initial dose